Xiaojuan Lu
- Cancer Research top 10%
- NF-κB Signaling Pathways 2
-
- Cell death mechanisms and regulation 5
- Ubiquitin and proteasome pathways 3
- Inflammasome and immune disorders 2
-
- interferon and immune responses 5
-
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 2
-
- Peer-to-Peer Network Technologies 1
- Journals
- Cell Death and Disease (3 papers)Genes & Development (2 papers)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaojuan Lu
13 papers receiving 913 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 281
- Pulmonary and Respiratory Medicine 369
- Molecular Biology 647
- Immunology 192
- Epidemiology 212
Countries citing papers authored by Xiaojuan Lu
This map shows the geographic impact of Xiaojuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Lu more than expected).
Fields of papers citing papers by Xiaojuan Lu
This network shows the impact of papers produced by Xiaojuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Lu. The network helps show where Xiaojuan Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojuan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2022 | 14 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 14 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 62 | |
| 11 | Chaperone-mediated autophagy is involved in the execution of ferroptosisbreakdown → | 2019 | 456 |
| 12 | 2018 | 152 | |
| 13 | 2017 | 56 | |
| 14 | 2016 | 106 | |
| 15 | 2015 | 1 | |
| 16 | 2011 | 1 |
About Xiaojuan Lu
Xiaojuan Lu is a scholar working on Immunology, Cancer Research, Parasitology, Molecular Biology and Obstetrics and Gynecology, having authored 16 papers that have together received 920 indexed citations. Recurring topics across this work include interferon and immune responses (5 papers), Cell death mechanisms and regulation (5 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers), Inflammasome and immune disorders (2 papers), NF-κB Signaling Pathways (2 papers) and Peer-to-Peer Network Technologies (1 paper). The work is most often cited by research in Cancer Research (281 citations), Pulmonary and Respiratory Medicine (369 citations), Molecular Biology (647 citations), Immunology (192 citations) and Epidemiology (212 citations). Xiaojuan Lu has collaborated with scholars based in China and United States. Frequent co-authors include Bing Shan, Junying Yuan, Heling Pan, Zheming Wu, Guowei Wu, Mengmeng Zhang, Yang Geng, Yuying Shi, Lihui Qian and Wei Liang. Their work appears in journals such as Cell Death and Disease, Genes & Development, Frontiers in Oncology, Nature Communications and Functional & Integrative Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.